麻省总医院率先采用新型脑深部刺激植入装置改进病人治疗
为了实现神经系统疾病的个性化治疗,麻省总医院的神经内科和神经外科团队于2020年7月7日在新英格兰地区完成了第一例新型脑深部刺激植入装置植入术。
Contact Information
Boston, MAPhone: 617-726-3642
Boston, MAPhone: 855-644-6387
Todd Herrington is a Neurologist at Massachusetts General Hospital and an Assistant Professor of Neurology at Harvard Medical School. Dr. Herrington completed his BS at Stanford University, followed by MD and PhD at Harvard Medical School, residency in Neurology at the joint Mass General Brigham Neurology Residency Program at Massachusetts General Hospital and Brigham and Women's Hospital, and a Fellowship in Movement Disorders at Massachusetts General Hospital.
In the Division of Movement Disorders, Dr. Herrington treats patients with Parkinson's disease, tremor, dystonia and other movement disorders, with an additional specialization in patients who are undergoing treatment with deep brain stimulation.
Dr. Herrington's research focuses on the impact of deep brain stimulation on the motor, cognitive and psychiatric manifestations of movement disorders. Using a combination of intraoperative neurophysiology, noninvasive neurophysiology and neuroimaging, Dr. Herrington aims to further our understanding of the role of the human basal ganglia in health and disease and to develop novel approaches to neuromodulation to treat motor and nonmotor symptoms.
Clinical Interests:
Treats:
Mass General Neurology: Neuromuscular
165 Cambridge St.
Charles River Plaza
Suite 820
Boston, MA 02114
Phone: 617-726-3642
Mass General Neurology
55 Fruit St.
Boston, MA 02114
Phone: 855-644-6387
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Herrington's research focuses on the impact of deep brain stimulation on the motor, cognitive and psychiatric manifestations of movement disorders. Using a combination of intraoperative neurophysiology, noninvasive neurophysiology and neuroimaging, Dr. Herrington aims to further our understanding of the role of the human basal ganglia in health and disease and to develop novel approaches to neuromodulation to treat motor and nonmotor symptoms. He has received support from the National Institutes of Health, the American Academy of Neurology and the Bachman-Strauss Dystonia & Parkinson Foundation.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
The Mukerji Lab for Neuroinfectious Diseases has an ongoing clinical trial for people with HIV and depression.
Mass General is recognized as a top hospital on the U.S. News Best Hospitals Honor Roll for 2024-2025.
为了实现神经系统疾病的个性化治疗,麻省总医院的神经内科和神经外科团队于2020年7月7日在新英格兰地区完成了第一例新型脑深部刺激植入装置植入术。
帕金森病是发展最快的神经系统疾病,目前尚无治愈方法。McLean医院和美国麻省总医院的一组科学家和医生在《新英格兰医学杂志》上报道了一种新的神经外科技术,一名帕金森氏症患者接受了从他自己的皮肤细胞中提取的多巴胺祖细胞移植到大脑中来治疗他的疾病。患者报告日常生活中运动功能改善,没有出现任何不良反应。
Neuroscience team is first in New England to offer patients new implant blending personal technology and standardized care
Reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease has been shown to be technically feasible, reports a team of investigators from McLean Hospital and Mass General.